Announcing the SFB Biomaterials and Medical Products Commercialization SIG

摘要

We are excited to announce that the name change of the Biomaterials Availability and Policy (BAP) Special Interest Group to the Biomaterials and Medical Products Commercialization (BMPC) Special Interest Group has been approved by Council. We agree that this new name better reflects the current purpose and mission of this SIG.